Previous studies have implicated an imbalance in the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) in the pathogenesis of several neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases. Here, NFKB1 is linked to juvenile Huntington disease.